![B. G. Susan Robinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
B.
G.
Susan Robinson has been President and Chief Executive Officer of Targeted Genetics Corp.
since November 6, 2008 and a Director since November 14, 2008.
Prior to Targeted Genetics, she was Director-Business Development of Genzyme Molecular Oncology.
Ms. Robinson held various positions for Immulogic Pharmaceuticals Corporation and T-Cell Sciences, Inc. She received a degree from Yale University.
Former positions of B. G. Susan Robinson
Companies | Position | End |
---|---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | President | - |
Training of B. G. Susan Robinson
Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- B. G. Susan Robinson